NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $674,000 | +10.0% | 8,072 | -2.2% | 0.33% | +4.8% |
Q1 2017 | $613,000 | -3.9% | 8,255 | -5.7% | 0.32% | -12.5% |
Q4 2016 | $638,000 | -11.3% | 8,755 | -3.8% | 0.36% | -15.3% |
Q3 2016 | $719,000 | -7.3% | 9,105 | -3.1% | 0.42% | -14.3% |
Q2 2016 | $776,000 | +19.8% | 9,400 | +5.0% | 0.50% | +13.5% |
Q1 2016 | $648,000 | -16.8% | 8,950 | -1.1% | 0.44% | -23.2% |
Q4 2015 | $779,000 | -11.3% | 9,050 | -5.2% | 0.57% | -14.9% |
Q3 2015 | $878,000 | -17.3% | 9,550 | -11.6% | 0.67% | -7.9% |
Q2 2015 | $1,062,000 | -0.3% | 10,800 | 0.0% | 0.73% | -0.4% |
Q1 2015 | $1,065,000 | +18.5% | 10,800 | +11.3% | 0.73% | -4.0% |
Q4 2014 | $899,000 | -2.5% | 9,700 | -1.0% | 0.76% | -8.0% |
Q3 2014 | $922,000 | +0.3% | 9,800 | -3.4% | 0.82% | +3.5% |
Q2 2014 | $919,000 | +5.5% | 10,150 | -1.0% | 0.80% | +3.4% |
Q1 2014 | $871,000 | +7.3% | 10,250 | +1.5% | 0.77% | +9.1% |
Q4 2013 | $812,000 | -1.9% | 10,100 | -6.5% | 0.71% | -11.3% |
Q3 2013 | $828,000 | +2.7% | 10,800 | -5.3% | 0.80% | -1.0% |
Q2 2013 | $806,000 | – | 11,400 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |